alexa Treatment Of Eczema With MMF: A Single Centre Ten Year Experience | 61904
ISSN: 2155-9554

Journal of Clinical & Experimental Dermatology Research
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

11th Global Dermatologists Congress
November 14-15, 2016 Dubai, UAE

Mark Lim
Northeast Medical Group, Singapore
Posters & Accepted Abstracts: J Clin Exp Dermatol Res
DOI: 10.4172/2155-9554.C1.045
Abstract
Background: Treatment of refractory atopic dermatitis or endogenous eczema can be challenging due to limited treatment modalities. MMF is a good alternative systemic therapy for chronic eczema but its costs often limit its use in Singapore. While there are a few small prospective studies done in the past decade on the efficacy of MMF in the treatment of eczema, data on its treatment efficacy and side effects remain anecdotal and especially lacking in an Asian population. Aims: To evaluate the effectiveness and side effects of MMF in its treatment of eczema among a cohort of Asian eczema patients. Methods: This is a retrospective chart review of eczema patients in our centre who were treated with MMF from 2006 to 2016. Patients were identified from electronic medical records by cross referencing clinic and pharmacy electronic records. Results: Our study included a total of 26 patients ranging from 14-87 years old. Most patients (53.8 %) had failed prior treatment with immunosuppressants and 26.9% of patients had prior phototherapy. The highest dose of MMF used was 1000-3000 mg. 88.5% had improvement of their eczema during follow-up. A total of eight patients (30.8%) reported complications during treatment. Most complications were mild and non-specific with six patients reporting worsening eczema or no improvement. No patients developed leukopenia or anemia during follow-up. Conclusion: MMF remains a useful therapeutic option in the treatment of eczema and could potentially be used as an early treatment option. Further cost effectiveness comparisons could be done with other immunosuppressants.
Biography

Email: [email protected]

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version